$CF
CF Industries Holdings, Inc.

2024 Q3 Form 10-Q Financial Statement

#000132440424000020 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $1.370B $1.572B
YoY Change 7.62% -11.44%
Cost Of Revenue $926.0M $893.0M
YoY Change 3.35% -8.03%
Gross Profit $444.0M $679.0M
YoY Change 17.77% -15.55%
Gross Profit Margin 32.41% 43.19%
Selling, General & Admin $78.00M $76.00M
YoY Change 14.71% 7.04%
% of Gross Profit 17.57% 11.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $229.0M $222.0M
YoY Change 7.51% 0.45%
% of Gross Profit 51.58% 32.7%
Operating Expenses $78.00M $76.00M
YoY Change 14.71% 1.33%
Operating Profit $364.0M $638.0M
YoY Change 49.18% -12.48%
Interest Expense $0.00 $37.00M
YoY Change -100.0% 208.33%
% of Operating Profit 0.0% 5.8%
Other Income/Expense, Net $4.000M $0.00
YoY Change 33.33% -100.0%
Pretax Income $400.0M $629.0M
YoY Change 58.1% -15.0%
Income Tax $59.00M $123.0M
% Of Pretax Income 14.75% 19.55%
Net Earnings $341.0M $506.0M
YoY Change 48.26% -3.98%
Net Earnings / Revenue 24.89% 32.19%
Basic Earnings Per Share $1.55 $2.30
Diluted Earnings Per Share $1.55 $2.30
COMMON SHARES
Basic Shares Outstanding 180.4M shares 182.8M shares
Diluted Shares Outstanding 178.6M shares 182.8M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.877B $1.819B
YoY Change -42.32% -43.49%
Cash & Equivalents $1.877B $1.819B
Short-Term Investments $501.0M $448.0M
Other Short-Term Assets $57.00M $64.00M
YoY Change 5.56% -56.16%
Inventory $301.0M $302.0M
Prepaid Expenses
Receivables $482.0M $531.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.850B $2.801B
YoY Change -31.98% -31.21%
LONG-TERM ASSETS
Property, Plant & Equipment $6.816B $6.830B
YoY Change 10.72% 5.14%
Goodwill $2.493B $2.493B
YoY Change 19.34% 19.34%
Intangibles $515.0M $522.0M
YoY Change
Long-Term Investments $28.00M $25.00M
YoY Change -12.5% -65.28%
Other Assets $869.0M $863.0M
YoY Change 8.76% 6.81%
Total Long-Term Assets $10.99B $10.97B
YoY Change 17.53% 15.94%
TOTAL ASSETS
Total Short-Term Assets $2.850B $2.801B
Total Long-Term Assets $10.99B $10.97B
Total Assets $13.84B $13.78B
YoY Change 2.22% 1.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $562.0M $501.0M
YoY Change 13.08% 11.09%
Accrued Expenses $86.00M $78.00M
YoY Change -14.85% -22.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.013B $596.0M
YoY Change 9.4% -4.18%
LONG-TERM LIABILITIES
Long-Term Debt $2.970B $2.970B
YoY Change 0.1% 0.1%
Other Long-Term Liabilities $270.0M $271.0M
YoY Change -6.25% -47.68%
Total Long-Term Liabilities $3.240B $3.241B
YoY Change -0.46% -7.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.013B $596.0M
Total Long-Term Liabilities $3.240B $3.241B
Total Liabilities $4.253B $3.837B
YoY Change 1.72% -50.38%
SHAREHOLDERS EQUITY
Retained Earnings $4.533B $4.360B
YoY Change -3.16% -9.11%
Common Stock $2.000M $2.000M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $483.0M $15.00M
YoY Change 219.87% -93.36%
Treasury Stock Shares
Shareholders Equity $5.194B $5.460B
YoY Change
Total Liabilities & Shareholders Equity $13.84B $13.78B
YoY Change 2.22% 1.76%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $341.0M $506.0M
YoY Change 48.26% -3.98%
Depreciation, Depletion And Amortization $229.0M $222.0M
YoY Change 7.51% 0.45%
Cash From Operating Activities $931.0M $475.0M
YoY Change 50.65% -33.29%
INVESTING ACTIVITIES
Capital Expenditures $139.0M $84.00M
YoY Change -5.44% -11.58%
Acquisitions
YoY Change
Other Investing Activities -$4.000M $50.00M
YoY Change -233.33% 2400.0%
Cash From Investing Activities -$143.0M -$34.00M
YoY Change -0.69% -63.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -745.0M -396.0M
YoY Change 72.85% 72.93%
NET CHANGE
Cash From Operating Activities 931.0M 475.0M
Cash From Investing Activities -143.0M -34.00M
Cash From Financing Activities -745.0M -396.0M
Net Change In Cash 43.00M 45.00M
YoY Change 0.0% -88.46%
FREE CASH FLOW
Cash From Operating Activities $931.0M $475.0M
Capital Expenditures $139.0M $84.00M
Free Cash Flow $792.0M $391.0M
YoY Change 68.15% -36.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Revenues
Revenues
3787000000 usd
us-gaap Cost Of Revenue
CostOfRevenue
2120000000 usd
us-gaap Gross Profit
GrossProfit
1667000000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
131000000 usd
cf Equity In Earnings Of Operating Affiliates
EquityInEarningsOfOperatingAffiliates
24000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1560000000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2032000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2323000000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1819000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3219000000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6000000 usd
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2024Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
91000000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8102000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8373000000 usd
us-gaap Profit Loss
ProfitLoss
744000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-23000000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
659000000 usd
us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 usd
cf Acquisition Of Treasury Stock Under Employee Stock Plans
AcquisitionOfTreasuryStockUnderEmployeeStockPlans
23000000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
19000000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.00
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
186000000 usd
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
144000000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8102000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8090000000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
606000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
25000000 usd
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
131000000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
78000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8520000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7853000000 usd
us-gaap Profit Loss
ProfitLoss
1256000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
31000000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
206000000 usd
cf Acquisition Of Treasury Stock Under Employee Stock Plans
AcquisitionOfTreasuryStockUnderEmployeeStockPlans
22000000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
19000000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.80
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
157000000 usd
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
255000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8520000000 usd
us-gaap Profit Loss
ProfitLoss
744000000 usd
us-gaap Profit Loss
ProfitLoss
1256000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
475000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
427000000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-70000000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-53000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
19000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
19000000 usd
cf Unrealized Gain Loss On Derivatives Fair Value Adjustment
UnrealizedGainLossOnDerivativesFairValueAdjustment
34000000 usd
cf Unrealized Gain Loss On Derivatives Fair Value Adjustment
UnrealizedGainLossOnDerivativesFairValueAdjustment
72000000 usd
cf Gain Loss On Sale Of Carbon Credits
GainLossOnSaleOfCarbonCredits
47000000 usd
cf Gain Loss On Sale Of Carbon Credits
GainLossOnSaleOfCarbonCredits
36000000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-6000000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
45000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-198000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-140000000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
63000000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
166000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-26000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-138000000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-122000000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-220000000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-38000000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-29000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
920000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1659000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
182000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
164000000 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
2000000 usd
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000000 usd
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
1000000 usd
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
0 usd
cf Payments To Acquire Emission Credits
PaymentsToAcquireEmissionCredits
2000000 usd
cf Payments To Acquire Emission Credits
PaymentsToAcquireEmissionCredits
0 usd
cf Proceeds From Sale Of Emission Credits
ProceedsFromSaleOfEmissionCredits
47000000 usd
cf Proceeds From Sale Of Emission Credits
ProceedsFromSaleOfEmissionCredits
36000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-134000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-127000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
188000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
158000000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
144000000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
255000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
644000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
205000000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
23000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
22000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-998000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-639000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-213000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
896000000 usd
CY2024Q2 us-gaap Revenues
Revenues
1572000000 usd
CY2023Q2 us-gaap Revenues
Revenues
1775000000 usd
us-gaap Revenues
Revenues
3042000000 usd
us-gaap Revenues
Revenues
3787000000 usd
CY2024Q2 us-gaap Deferred Revenue
DeferredRevenue
8000000 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
130000000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1900000000 usd
CY2024Q2 cf Revenue Remaining Performance Obligation Expected Timingof Satisfaction Percent
RevenueRemainingPerformanceObligationExpectedTimingofSatisfactionPercent
0.18
CY2024Q2 cf Revenue Remaining Performance Obligation Expected Timingof Satisfaction Percent
RevenueRemainingPerformanceObligationExpectedTimingofSatisfactionPercent
0.19
CY2024Q2 cf Revenue Remaining Performance Obligation Expected Timingof Satisfaction Percent
RevenueRemainingPerformanceObligationExpectedTimingofSatisfactionPercent
0.19
CY2024Q2 cf Revenue Remaining Performance Obligation Expected Timingof Satisfaction Percent
RevenueRemainingPerformanceObligationExpectedTimingofSatisfactionPercent
0.19
CY2024Q2 cf Revenue Remaining Performance Obligation Expected Timingof Satisfaction Percent
RevenueRemainingPerformanceObligationExpectedTimingofSatisfactionPercent
0.17
CY2024Q2 cf Revenue Remaining Performance Obligation Expected Timingof Satisfaction Percent
RevenueRemainingPerformanceObligationExpectedTimingofSatisfactionPercent
0.17
CY2024Q2 cf Revenue Performance Obligationdescriptionofreturnsandothersimilarobligationsunfulfilledminimumcontractualrightofpayment
RevenuePerformanceObligationdescriptionofreturnsandothersimilarobligationsunfulfilledminimumcontractualrightofpayment
1300000000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
420000000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
527000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
614000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1087000000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
182700000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
194600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
185100000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
195400000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.30
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.56
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
182700000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
194600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
185100000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
195400000 shares
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
100000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
400000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
400000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
500000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
182800000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
195000000.0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
185500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
195900000 shares
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.30
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.70
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.55
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1000000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
4000000 usd
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3000000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
16000000 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
253000000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
256000000 usd
CY2024Q2 cf Inventory Raw Materials Spare Parts And Supplies Net Of Reserves
InventoryRawMaterialsSparePartsAndSuppliesNetOfReserves
49000000 usd
CY2023Q4 cf Inventory Raw Materials Spare Parts And Supplies Net Of Reserves
InventoryRawMaterialsSparePartsAndSuppliesNetOfReserves
43000000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
302000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
299000000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15270000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15244000000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8440000000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8103000000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6830000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7141000000 usd
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
71000000 usd
CY2023 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
68000000 usd
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
63000000 usd
CY2022 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
53000000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
220000000 usd
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
472000000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
218000000 usd
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
422000000 usd
CY2024Q2 us-gaap Cash
Cash
225000000 usd
CY2024Q2 us-gaap Cash
Cash
225000000 usd
CY2023Q4 us-gaap Cash
Cash
208000000 usd
CY2023Q4 us-gaap Cash
Cash
208000000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
123000000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
629000000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.195
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
134000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
740000000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.182
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
185000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
929000000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.199
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
303000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1560000000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.195
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.195
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
629000000 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
86000000 usd
CY2024Q2 cf Effective Income Tax Rate Reconciliation Period Increasedecrease Due To Noncontrolling Interest
EffectiveIncomeTaxRateReconciliationPeriodIncreasedecreaseDueToNoncontrollingInterest
0.031
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
86000000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.182
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
79000000 usd
CY2023Q2 cf Effective Income Tax Rate Reconciliation Period Increasedecrease Due To Noncontrolling Interest
EffectiveIncomeTaxRateReconciliationPeriodIncreasedecreaseDueToNoncontrollingInterest
0.021
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
79000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
929000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
130000000 usd
cf Effective Income Tax Rate Reconciliation Period Increasedecrease Due To Noncontrolling Interest
EffectiveIncomeTaxRateReconciliationPeriodIncreasedecreaseDueToNoncontrollingInterest
0.032
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
130000000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.195
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
169000000 usd
cf Effective Income Tax Rate Reconciliation Period Increasedecrease Due To Noncontrolling Interest
EffectiveIncomeTaxRateReconciliationPeriodIncreasedecreaseDueToNoncontrollingInterest
0.023
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
169000000 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3000000000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
2970000000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3000000000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
2968000000 usd
CY2024Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
38000000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
37000000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
75000000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
74000000 usd
CY2024Q2 cf Fee On Financing Agreements Amount
FeeOnFinancingAgreementsAmount
2000000 usd
CY2023Q2 cf Fee On Financing Agreements Amount
FeeOnFinancingAgreementsAmount
2000000 usd
cf Fee On Financing Agreements Amount
FeeOnFinancingAgreementsAmount
4000000 usd
cf Fee On Financing Agreements Amount
FeeOnFinancingAgreementsAmount
4000000 usd
CY2024Q2 cf Interest On Tax Liabilities
InterestOnTaxLiabilities
0 usd
CY2023Q2 cf Interest On Tax Liabilities
InterestOnTaxLiabilities
-2000000 usd
cf Interest On Tax Liabilities
InterestOnTaxLiabilities
0 usd
cf Interest On Tax Liabilities
InterestOnTaxLiabilities
0 usd
CY2024Q2 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
3000000 usd
CY2023Q2 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
1000000 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
5000000 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
2000000 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
37000000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
36000000 usd
us-gaap Interest Expense
InterestExpense
74000000 usd
us-gaap Interest Expense
InterestExpense
76000000 usd
CY2024Q2 cf Notional Nonmonetary Amountof Price Risk Derivative Instruments Not Designatedas Hedging Instruments
NotionalNonmonetaryAmountofPriceRiskDerivativeInstrumentsNotDesignatedasHedgingInstruments
9000000 mmbtu
CY2023Q4 cf Notional Nonmonetary Amountof Price Risk Derivative Instruments Not Designatedas Hedging Instruments
NotionalNonmonetaryAmountofPriceRiskDerivativeInstrumentsNotDesignatedasHedgingInstruments
49000000 mmbtu
cf Percentage Of Consumption Hedged By Derivatives
PercentageOfConsumptionHedgedByDerivatives
0.27
CY2024Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
CY2023Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-4000000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-46000000 usd
CY2024Q2 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
0 usd
CY2023Q4 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
34000000 usd
CY2023Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 usd
CY2024Q2 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
0 usd
CY2021Q4 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1500000000 usd
CY2022Q4 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
3000000000 usd
cf Stock Repurchase Accrued But Unpaid
StockRepurchaseAccruedButUnpaid
14000000 usd
CY2024Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
8400000 shares
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
200000 shares
CY2024Q2 us-gaap Revenues
Revenues
1572000000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
893000000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
679000000 usd
CY2024Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
38000000 usd
CY2024Q2 cf Equity In Earnings Of Operating Affiliates
EquityInEarningsOfOperatingAffiliates
-3000000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
638000000 usd
CY2023Q2 us-gaap Revenues
Revenues
1775000000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
971000000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
804000000 usd
CY2023Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
77000000 usd
CY2023Q2 cf Equity In Earnings Of Operating Affiliates
EquityInEarningsOfOperatingAffiliates
7000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
734000000 usd
us-gaap Revenues
Revenues
3042000000 usd
us-gaap Cost Of Revenue
CostOfRevenue
1954000000 usd
us-gaap Gross Profit
GrossProfit
1088000000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
146000000 usd
cf Equity In Earnings Of Operating Affiliates
EquityInEarningsOfOperatingAffiliates
-1000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
941000000 usd
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001324404-24-000020-index-headers.html Edgar Link pending
0001324404-24-000020-index.html Edgar Link pending
0001324404-24-000020.txt Edgar Link pending
0001324404-24-000020-xbrl.zip Edgar Link pending
cf-06302024xex101.htm Edgar Link pending
cf-06302024xex102.htm Edgar Link pending
cf-06302024xex311.htm Edgar Link pending
cf-06302024xex312.htm Edgar Link pending
cf-06302024xex321.htm Edgar Link pending
cf-06302024xex322.htm Edgar Link pending
cf-20240630.htm Edgar Link pending
cf-20240630.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
picture1a.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
cf-20240630_lab.xml Edgar Link unprocessable
cf-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cf-20240630_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cf-20240630_cal.xml Edgar Link unprocessable
cf-20240630_def.xml Edgar Link unprocessable